CAS 328933-56-8

Bazedoxifene-5-Glucuronide

CAS : 328933-56-8

Formule : C₃₆H₄₂N₂O₉

Couleur et forme : Off-White Solid

Masse moléculaire : 646.74

Ref: 4Z-B-484

Bazedoxifene-5-Glucuronide-d4

CAS : 328933-56-8

Formule : C₃₆H₃₈N₂O₉D₄

Couleur et forme : White To Off-White Solid

Masse moléculaire : 650.77

Ref: 4Z-B-488

Bazedoxifene 5-β-D-Glucuronide

Produit contrôlé

CAS : 328933-56-8

Formule : C₃₆H₄₂N₂O₉

Couleur et forme : Neat

Masse moléculaire : 646.727

Ref: TR-B129275

Bazedoxifene-d4 5-β-D-Glucuronide

Produit contrôlé

CAS : 328933-56-8

Formule : C₃₆H₃₈D₄N₂O₉

Couleur et forme : Neat

Masse moléculaire : 650.76

Ref: TR-B129277

Bazedoxifene 5-β-D-glucuronide

CAS : 328933-56-8

Bazedoxifene 5-β-D-glucuronide is an analog of bazedoxifene, a selective estrogen receptor modulator used in the treatment of osteoporosis. This compound has shown promising anticancer properties and has been studied extensively in Chinese hamster ovary cells. Bazedoxifene 5-β-D-glucuronide has been found to induce apoptosis in cancer cells and inhibit the activity of kinases involved in tumor growth. It is a potent inhibitor of several human protein kinases, including cyclin-dependent kinase 2 (CDK2) and glycogen synthase kinase 3 beta (GSK3β), which are important targets for medicinal chemists developing kinase inhibitors. This compound is excreted primarily in urine and may have potential as a therapeutic agent for various types of cancer.

Formule : C₃₆H₄₂N₂O₉

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 646.7 g/mol

Ref: 3D-DNA93356

Bazedoxifene-5-Glucuronide

CAS : 328933-56-8

Formule : C₃₆H₄₂N₂O₉

Masse moléculaire : 646.74

Ref: ST-EA-CP-B41011